Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8 <sup>+</sup> and PD-1 <sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors

Routinely quantifying intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> cells with a clinically validated digital pathology platform predicts patient survival across major cancer types, independent of clinical stage and despite diverse treatment regimens.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-09-01
DOI
https://doi.org/10.1200/po-25-00240
Citations
3
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
3.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8 + and PD-1 + Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors

Jennifer Curtis, Tali Mazor, Xinan Wang, Marta Holovatska et al.
3 citations
JCO Precision Oncology
Cancer Immunotherapy and Biomarkers
3.14
article

Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8 + and PD-1 + Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors

Jennifer Curtis, Tali Mazor, Xinan Wang, Marta Holovatska, Federica Pecci, Sandro Santagata, Eddy Saad, Bijaya Sharma, Melissa E. Hughes, Jason L. Weirather, Margaret A. Shipp, Kristen D. Felt, Jennifer Altreuter, Biagio Ricciuti, Tess A. O’Meara, Neal I. Lindeman, Glenn J. Hanna, William Lotter, Xiao X. Wei, Sabina Signoretti, Nancy U. Lin, Toni K. Choueiri, Bruce E. Johnson, Jonathan Andrew Nowak, Scott J. Rodig, David Allen Barbie, Katharina Hoebel, Joyce F. Liu, Peter Karl Sorger, James Lindsay, Elio Adib, Sara M. Tolaney, Michael P. Manos, Frank S. Hodi, Alessandro Di Federico, Ethan Cerami, Anita Giobbie‐Hurder, Ian Dryg, Kathleen L. Pfaff, Panagiotis A. Konstantinopoulos, Malini Gandhi, Joao V. Alessi, Mark M. Awad, Sabrina Chan, Lynette M. Sholl, Priti Kumari, Fatme Ghandour
article en
3 citations

Abstract

Routinely quantifying intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> cells with a clinically validated digital pathology platform predicts patient survival across major cancer types, independent of clinical stage and despite diverse treatment regimens.

JCO Precision OncologyVol. 9(9)
Brigham and Women's Hospital (US), Harvard University (US), Cancer Research And Biostatistics (US), Dana-Farber Cancer Institute (US), Center for Systems Biology (US)
Openalex Percentile: Top 7%
Cancer Immunotherapy and Biomarkers
3.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.